Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06125522
Title TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL


No variant requirements are available.